Eyes Down For Reckitt Benckiser Group Plc’s Results

We’ll see how Reckitt Benckiser Group Plc (LON: RB) fared in 2013.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Reckitt Benckiser Group (LSE: RB) (NASDAQOTH: RBGLY.US) shares have had a mixed ride — they’re up around 11% over 12 months to 4,656p, against a 3% rise for the FTSE 100, but it’s been a bit volatile.

The company was seen as something of a safe haven back in recession time, and its earnings were going strong — in 2009, we saw a 24% rise in earnings per share (EPS). But that growth has been slowing, down to just 7% by 2012. And analysts are actually expecting a modest fall of 1% for the year just ended in December 2013, with the same penciled in for 2014.

Results next week

Whether they’re right is something we shall find out on Wednesday 12 February, when we’ll have those 2013 results. But how has the year been going so far?

In third-quarter results released in October 2013, the owner of an array worldwide consumer brands reported like-for-like revenue growth of 5% for the quarter and the same for the year-to-date, excluding its pharmaceuticals business (RBP). Chief executive Rakesh Kapoor told us that the firm’s focus on health and hygiene and emerging markets was “delivering good results“.

And of RBP, he said “…we are commencing a strategic review of the business and will consider all options for maximising value for our shareholders. We expect the review to take some time and will update shareholders during the course of 2014“.

Prospects?

What of the full-year? Well, Mr Kapoor used that nasty “challenging” word when describing market conditions, but predicted full-year revenue growth of at least 6% with margins expected to be maintained.

Looking back further, statutory first-half EPS reported in July 2013 dropped 14% to 90.4p, though the company claimed a 7% rise to 118.3p for adjusted EPS. Like-for-like revenue at the time was up 6%, excluding RBP, with adjusted operating profit up 2% (though statutory operating profit fell 17%).

Looking at the spread of analysts’ opinions in the light of the year so far, I think Reckitt Benckiser’s 2013 EPS could be anywhere in a range of a few percent down to a few percent up.

Dividends

But what about dividends? Reckitt Benckiser traditionally provides a fairly average annual yield of a little over 3%, though it did rise a bit above that in the past couple of years as the share price fell back a little.

There’s a modest 3% rise in the 2013 dividend expected, to take it to about 138p per share for a yield of 3%. But the first-half dividend was lifted by 7% to 60p per share, so if anything that could be a bit conservative — in fact, the most recent forecasts are suggesting around 140p per share.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

> Alan does not own any shares in Reckitt Benckiser.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »